Approval · Notice of Compliance 24364 · 2020
TELZIR: Notice of Compliance 24364
Issued October 2, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24364
- Date
- October 2, 2020
- Company
- Viiv Healthcare UlcMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the telzir tablets bottle label into extended content label format
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TELZIR | Not yet assigned | — |
Medicinal ingredients
- FOSAMPRENAVIR CALCIUM 700 MG per TAB